Company overview
Abselion develops the Amperia benchtop platform using proprietary Redox Electrochemical Detection (RED) technology for fast, accurate quantification of proteins, antibodies, and viral vectors without optics or fluidics. The system simplifies workflows in life sciences, biotech, and therapeutic development with ready-to-use kits like Protein G for broad IgG subclass and species titre measurement. Based in Cambridge, UK, with a new US subsidiary, it supports research, process development, and bioprocessing for reliable data from complex samples.
Quantification Simplified is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents partner serving United States & Americas. Core focus areas include protein quantification, antibody titre, amperia platform, viral vector analysis, bioprocessing tools.
Industry categories: Life Science Reagents. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.abselion.com
- Categories
- Life Science Reagents
- Markets served
- United States & Americas
- Keywords
- protein quantification, antibody titre, amperia platform, viral vector analysis, bioprocessing tools
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What is Abselion's main technology and capabilities?
- Abselion's Amperia platform uses RED technology for automated, dip-and-read quantification of proteins, total antibodies via Protein G/A kits, and viral vectors, delivering real-time results without optics, fluidics, or specialist training.
- What regulatory or compliance features does Amperia offer?
- Amperia provides reproducible, accurate results from complex samples with intuitive software guidance, suitable for research and process development; specific regulatory certifications are not detailed, but it minimizes errors in bioprocessing workflows.
- Where does Abselion operate and provide support?
- Headquartered in Cambridge, UK, Abselion has launched a US subsidiary for localized technical expertise and collaboration with North American biotech and pharma partners.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
